Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 2 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 12 % of short-term debt in 2024; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
COMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE from Sint-Agatha-Berchem, company number BE0501544636, closed financial year 2024 with a result of € 0 after tax. For that financial year COMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE recorded a gross margin of € 0 and equity of € -64,424. Compared with financial year 2022, the result moved from € -1,005 to € 0. Around break-even. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.
€ -64,424
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
▲ still € 1,005 loss in 2022
Profit after tax over the fiscal year.
€ 8,863
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € -125,924.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
| 2022 | 2024 | Change 2022 → 2024 | |
|---|---|---|---|
| Gross margin | € -175 | € 0 | ▲ € 175 |
| Profit after taxes | € -1,005 | € 0 | ▲ € 1,005 |
| Equity | € -64,424 | € -64,424 | |
| Total debts | € 73,286 | € 73,286 | |
| Cash | € 8,863 | € 8,863 | |
| Retained profit | € -125,924 | € -125,924 | |
| Balance sheet total | € 8,863 | € 8,863 |
Key figures of COMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to COMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE?
What happened at COMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 0. filed late Source: NBB ↗
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,005 loss in 2022 to € 0 profit in 2024.
Establishments
Establishment units
Physical locations of this company
Kasterlindenstraat 128
1082 Sint-Agatha-Berchem
de Meeûssquare 37
1000 Brussel
Active since 26 November 2012
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →FRANCIRENE
€ 0 gross margin · 2025
ATELIER RELIEF
€ 2,802 revenue · 2025
COMPPASS
€ 25,000 revenue · 2025
XL VISION
€ 117,500 revenue · 2025
KANOPE CONSULTING SCS
€ 183,500 revenue · 2025
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0501.544.636
- VAT number
- BE 0501.544.636
- Registered office
- Kasterlindenstraat 128, 1082 Sint-Agatha-Berchem
- Names & denominations
- COMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 November 2012
- Peppol
- Not registered